Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 12Lymphoid 10Classical hematology 10Plasma cell 7Other neoplasm 5Myeloid 3Dermatologic 3Thoracic 1Breast 1

Conditions

Lung Neoplasms 3Anemia 3Multiple Myeloma 2Lymphoma 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Precancerous Conditions 1Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Neoplasms 1Myeloproliferative Disorders 1Leukemia 1Esophageal Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Azacitidine 3Polymerase Chain Reaction 2Counseling 2Bupropion 2tanespimycin 1sargramostim 1ruxolitinib 1rucaparib 1ribociclib 1pembrolizumab 1motexafin gadolinium 1incomplete Freund's adjuvant 1cc-486 1abiraterone 1Zinc Oxide 1Varenicline 1Uncertainty 1Tobacco Use Cessation Devices 1Tissue Banks 1Tinzaparin 1Radiotherapy 1Psychosocial Intervention 1Psychiatric Rehabilitation 1Paclitaxel 1Observation 1Nicotine Replacement Therapy 1Nicotine 1Methylprednisolone 1Melphalan 1Interleukin-15 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia × Epoetin Alfa × Thoracic × Clear all
NCT00003600 2016-07-13

Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy

Alliance for Clinical Trials in Oncology

Phase 3 Completed
344 enrolled
BreastClassical hematologyLymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cellThoracic

Anemia, Breast Neoplasms, Leukemia, Lung Neoplasms, Lymphoma, Multiple Myeloma, Myeloproliferative Disorders, Precancerous Conditions, Neoplasms, Plasma Cell, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡